Q32 Bio (QTTB) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.23% |
| Dec 31, 2025 | 327.74% |
| Sep 30, 2025 | -50.78% |
| Jun 30, 2025 | -204.81% |
| Mar 31, 2025 | -170.73% |
| Dec 31, 2024 | -68.98% |
| Sep 30, 2024 | -45.41% |
| Jun 30, 2024 | -31.29% |
| Mar 31, 2024 | 126.66% |
| Dec 31, 2023 | -16.92% |
| Sep 30, 2023 | -9.62% |
| Jun 30, 2023 | -3.99% |
| Mar 31, 2023 | -4.99% |
| Dec 31, 2022 | -162.52% |
| Sep 30, 2022 | -13.00% |
| Jun 30, 2022 | -9.75% |
| Mar 31, 2022 | 56.94% |
| Dec 31, 2021 | -14.56% |
| Sep 30, 2021 | -11.58% |
| Jun 30, 2021 | 11.82% |
| Mar 31, 2021 | 2.47% |
| Dec 31, 2020 | 15.14% |
| Sep 30, 2020 | -12.57% |
| Jun 30, 2020 | -14.05% |
| Mar 31, 2020 | -12.37% |
| Dec 31, 2019 | 0.27% |
| Sep 30, 2019 | -9.45% |
| Jun 30, 2019 | 63.40% |
| Mar 31, 2019 | -11.25% |
| Dec 31, 2018 | -8.32% |
| Sep 30, 2018 | -5.88% |
| Jun 30, 2018 | 562.37% |
| Mar 31, 2018 | -24.75% |